The latter. Many countries have bought a mix of both, the advantage of mRNA tech was always its adaptability hence why these are coming out first. Oxford vacc

The latter. Many countries have bought a mix of both, the advantage of mRNA tech was always its adaptability hence why these are coming out first. Oxford vaccine is reported likely to be approved for use in UK in less than two weeks’ time, for roll out first week of Jan